IDEX IDEX BIOMETRICS ASA

Grant of Incentive Subscription Rights in IDEX Biometrics 17 April 2024

Grant of Incentive Subscription Rights in IDEX Biometrics 17 April 2024

The board of directors of IDEX Biometrics ASA resolved on 17 April 2024 to issue 550,000 incentive subscription rights to employees in the IDEX Biometrics group. The grant was made under the company's 2023 incentive subscription rights plan as amended at the extraordinary general meeting on 21 December 2023. The exercise price of the subscription rights is NOK 0.15 per share and the SRs vest by 50% per year over two years. The SRs expire on 23 May 2028. Following the grant there are 18,023,725 subscription rights outstanding in IDEX Biometrics.

Primary insiders

IDEX discloses transactions by the following primary insider, who were granted incentive subscription rights (SRs) to IDEX shares ISIN NO0013107490:

–   CEO Vince Graziani was granted 250,000 SRs at NOK 0.15 per share

–   CTO Anthony Eaton was granted 150,000 SRs at NOK 0.15 per share

–   CCO Catharina Eklof was granted 150,000 SRs at NOK 0.15 per share

For further information contact:

Marianne Bøe, Head of Investor Relations

E-mail:

Tel: + 47 918 00186

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. 

About this notice 

This notice was published by Erling Svela, Vice president of finance, on 17 April 2024 at 20:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 5‑8 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5‑12 of the STA.



EN
17/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

Mandatory notice of shareholding 27 August 2025

Mandatory notice of shareholding 27 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 9,40% of the shares and voting rights in IDEX. Sundt AS will hold 2,804,915 shares in IDEX. The ownership will represent 4,93% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section...

 PRESS RELEASE

IDEX Biometrics ASA: First half 2025 report

IDEX Biometrics ASA: First half 2025 report IDEX Biometrics ASA's first half 2025 report is attached to this notice. Recent highlights: Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-yearAt the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024....

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 26 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 2 of the private placement amounted to 4,359,315 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten. The shares – 4,359,315 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,555,213 shares or 20,3 % shares of the tot...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and ...

 PRESS RELEASE

Mandatory notice of shareholding 22 August 2025

Mandatory notice of shareholding 22 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 10,26% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch